Intra-Cellular Therapies Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, has promoted Michael Halstead, J.D. to the position of President.   Halstead is currently serving as Executive Vice President and General Counsel. In this newly created leadership role, he will oversee several functions within the company, including legal, human resources, manufacturing & supply chain, quality, compliance, i...